Xeris Biopharma Holdings, Inc. · NASDAQ:XERS
Brady James Aloysius sold 10,834 Xeris Biopharma Holdings, Inc. shares (Form 4)
Traded Mar 30, 2026 · Filed Apr 1, 2026
On Mar 30, 2026, Brady James Aloysius (Director) sold 10,834 Xeris Biopharma Holdings, Inc. shares at US$5.54 for US$60,020 under a trading plan, leaving 89,166 shares. Filed Apr 1, 2026 (Form 4).
- Sold
- 10,834 shares
- Price
- US$5.54
- Value
- US$60,020
- Holding after
- 89,166 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Common Stock | Sale | 10,834 | US$5.54 | 89,166 | Direct |
Source
Related
- Xeris Biopharma Holdings, Inc.
- Brady James Aloysius
- Xeris Biopharma Holdings, Inc. shareholders
- Form 4 · Brady James Aloysius · Jun 5, 2026
- Form 4 · Hecht Beth · Oct 2, 2026
- Form 4 · McCulloch Kevin · Oct 2, 2026
- Form 4 · Pieper Steven · Oct 2, 2026
- Form 4 · McCulloch Kevin · Sep 29, 2026
- Form 4 · McCulloch Kevin · Sep 1, 2026